Search
for
Sort by
Research 511–540 of 1000+
- The G1/S transition in mammalian stem cells in vivo is autonomously regulated by cell size
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Intrinsic activation of cell growth and differentiation in ex vivo cultured human hair follicles by a transient endogenous production of ROS
- The Harmonies Played by TGF-β in Stem Cell Biology
- Effects of 5‐alpha reductase inhibitors on lung function: A reason for discontinuation duringCOVID‐19 pandemic?
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- GSDMA deficiency impairs cutaneous squamous cell carcinoma growth
- Sequential Scalp Assessment in Hair Regeneration Therapy Using an Adipose-Derived Stem Cell–Conditioned Medium
- Stem cell dynamics, migration and plasticity during wound healing
- Modulating the stem cell niche for tissue regeneration
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression
- Glutamine Metabolism Controls Stem Cell Fate Reversibility and Long-Term Maintenance in the Hair Follicle
- Stem Cell-Based Tissue Engineering for the Treatment of Burn Wounds: A Systematic Review of Preclinical Studies
- Characterisation of cell cycle arrest and terminal differentiation in a maximally proliferative human epithelial tissue: Lessons from the human hair follicle matrix
- Establishment of keratinocyte cell lines from human hair follicles
- Androgenic Alopecia: Cross-Talk Between Cell Signal Transduction Pathways
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- The Role of Janus Kinase Inhibitors in Dermatology
- From basic biology to engineered therapies: the keratinocyte stem cell playbook
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Extracellular Matrix as a Regulator of Epidermal Stem Cell Fate
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- 6-Gingerol inhibits hair cycle via induction of MMP2 and MMP9 expression
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Computational Evaluation of Dibenzo Compounds as Potential Dual Inhibitors of Androgen Receptor and 5α-Reductase
- Deletion of the Developmentally Essential Gene ATR in Adult Mice Leads to Age-Related Phenotypes and Stem Cell Loss